Atlas Trials

Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers

Clinical trial NCT06918951 · RECRUITING

Trial details

NCT number
NCT06918951
Sponsor
British Columbia Cancer Agency
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
OligoprogressionOligometastatic DiseaseOligoProgressive Metastatic Disease
Start date
2025-12-04
Primary completion
2030-06-01
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.